Le Lann A D, Fournié G J, Boissier L, Toutain P L, Benoist H
Institut National de la Santé et de la Recherche Médecale (INSERM) Unité 395, Toulouse, France.
Cancer Immunol Immunother. 1994 Sep;39(3):185-92. doi: 10.1007/BF01533385.
A qualitative impairment of natural killer (NK) function and the presence of circulating DNA have been independently reported in clinical situations such as cancer and lupus. The existence of receptors for chromatin fragments at the leukocyte membrane raised the question of the relation between the presence of chromatin fragments in the extracellular medium and the impairment of NK function. The present study shows that plasmas from patients with metastatic cancer and with pathological DNA concentrations inhibited significantly the NK activity of normal lymphocytes as compared to cancer plasmas with DNA concentrations in the normal range. In vitro, it was demonstrated that chromatin fragments inhibited the NK-mediated cytotoxicity in a dose-dependent manner. Inhibitory concentrations of nucleosomes (2.5-10 micrograms/ml) were lower than those of DNA and histones alone (100 micrograms/ml). Inhibitory effects of nucleosomes, DNA and histones differed also according to the effector population used: nucleosomes were effective whatever the CD56+ cell enrichment of the effector population, while DNA inhibition needed T cells, and histone inhibition probably resulted from a subtoxic effect, prevented by the presence of adherent cells. Finally we found that nucleosomes could inhibit the NK function only when they were present in the extracellular medium. Taken together, these data suggest that the persistence of nucleosomal DNA at sites of cell death or in the blood might be responsible, at least partly, for the NK activity impairment observed in pathological circumstances characterized by a high rate of cell death phenomena such as cancer.
在癌症和狼疮等临床情况中,自然杀伤(NK)功能的定性损伤以及循环DNA的存在已被分别报道。白细胞膜上存在染色质片段受体,这引发了细胞外介质中染色质片段的存在与NK功能损伤之间关系的问题。本研究表明,与DNA浓度在正常范围内的癌症患者血浆相比,转移性癌症患者且DNA浓度处于病理水平的血浆显著抑制正常淋巴细胞的NK活性。在体外,已证明染色质片段以剂量依赖方式抑制NK介导的细胞毒性。核小体的抑制浓度(2.5 - 10微克/毫升)低于单独的DNA和组蛋白(100微克/毫升)。核小体、DNA和组蛋白的抑制作用也因所使用的效应细胞群体而异:无论效应细胞群体中CD56 +细胞的富集情况如何,核小体都有效,而DNA抑制需要T细胞,组蛋白的抑制可能是由亚毒性效应导致的,贴壁细胞的存在可阻止这种效应。最后,我们发现核小体只有在细胞外介质中存在时才能抑制NK功能。综上所述,这些数据表明,核小体DNA在细胞死亡部位或血液中的持续存在可能至少部分地导致了在以高细胞死亡现象发生率为特征的病理情况下(如癌症)观察到的NK活性损伤。